Literature DB >> 23206703

Forced interaction of cell surface proteins with Derlin-1 in the endoplasmic reticulum is sufficient to induce their dislocation into the cytosol for degradation.

Sunglim Cho1, Miriam Lee, Youngsoo Jun.   

Abstract

Aberrantly folded proteins in the endoplasmic reticulum (ER) are rapidly removed into the cytosol for degradation by the proteasome via an evolutionarily conserved process termed ER-associated protein degradation (ERAD). ERAD of a subset of proteins requires Derlin-1 for dislocation into the cytosol; however, the molecular function of Derlin-1 remains unclear. Human cytomegalovirus US11 exploits Derlin-1-dependent ERAD to degrade major histocompatibility complex class I (MHC-I) molecules for immune evasion. Because US11 binds to both MHC-I molecules and Derlin-1 via its luminal and transmembrane domains (TMDs), respectively, the major role of US11 has been proposed to simply be delivery of MHC-I molecules to Derlin-1. Here, we directly tested this proposal by generating a hybrid MHC-I molecule, which contains the US11 TMD, and thus can associate with Derlin-1 in the absence of US11. Intriguingly, this MHC-I hybrid was rapidly degraded in a Derlin-1- and proteasome-dependent manner. Similarly, the vesicular stomatitis virus G protein, otherwise expressed at the cell surface, was degraded via Derlin-1-dependent ERAD when its TMD was replaced with that of US11. Thus, forced interaction of cell surface proteins with Derlin-1 is sufficient to induce their degradation via ERAD. Taken together, these results suggest that the main role of US11 is to recruit MHC-I molecules to Derlin-1, which then mediates the dislocation of MHC-I molecules into the cytosol for degradation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23206703     DOI: 10.1016/j.bbrc.2012.11.068

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Derlin-1 is overexpressed in human colon cancer and promotes cancer cell proliferation.

Authors:  Xueming Tan; Xiaolu He; Zhonghua Jiang; Xiaohong Wang; Limei Ma; Li Liu; Xiang Wang; Zhining Fan; Dongming Su
Journal:  Mol Cell Biochem       Date:  2015-07-15       Impact factor: 3.396

2.  The C-terminal amino acid of the MHC-I heavy chain is critical for binding to Derlin-1 in human cytomegalovirus US11-induced MHC-I degradation.

Authors:  Sunglim Cho; Bo Young Kim; Kwangseog Ahn; Youngsoo Jun
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

Review 3.  Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver?

Authors:  Anne Halenius; Carolin Gerke; Hartmut Hengel
Journal:  Cell Mol Immunol       Date:  2014-11-24       Impact factor: 11.530

4.  High Expression of Derlin-1 Is Associated with the Malignancy of Bladder Cancer in a Chinese Han Population.

Authors:  Ziyu Wu; Chao Wang; Zhan Zhang; Wenlou Liu; Hengsen Xu; Huanqiang Wang; Yun Wang; Wei Zhang; Shou-Lin Wang
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

5.  Abnormally decreased renal Klotho is linked to endoplasmic reticulum-associated degradation in mice.

Authors:  ShaSha Li; JiaWei Kong; LiXia Yu; QiFeng Liu
Journal:  Int J Med Sci       Date:  2022-01-09       Impact factor: 3.738

6.  A high-coverage shRNA screen identifies TMEM129 as an E3 ligase involved in ER-associated protein degradation.

Authors:  Michael L van de Weijer; Michael C Bassik; Rutger D Luteijn; Cornelia M Voorburg; Mirjam A M Lohuis; Elisabeth Kremmer; Rob C Hoeben; Emily M LeProust; Siyuan Chen; Hanneke Hoelen; Maaike E Ressing; Weronika Patena; Jonathan S Weissman; Michael T McManus; Emmanuel J H J Wiertz; Robert Jan Lebbink
Journal:  Nat Commun       Date:  2014-05-08       Impact factor: 14.919

Review 7.  ERAD and how viruses exploit it.

Authors:  Hyewon Byun; Yongqiang Gou; Adam Zook; Mary M Lozano; Jaquelin P Dudley
Journal:  Front Microbiol       Date:  2014-07-03       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.